Form D · Biotechnology
CereSpir Inc
New York, NY · CIK 0001683746
Offering snapshot reported Sep 13, 2016 · SEC filing
- Reported sold
- $500K Offering amount: $500K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 30, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 13, 2016 | Initial | $500,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-270545
Source: Form D, filed Sep 13, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel G. Chain | Director, Executive |
| Adrian N. Hobden | Director, Executive |
| Michael G. Jesselson | Director |
| Samuel Jesselson | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
41 Madison Avenue 31 St Floor
New York, NY, 10010
New York, NY, 10010